203 related articles for article (PubMed ID: 28505188)
21. Risk factors for mortality before age 18 years in cystic fibrosis.
McColley SA; Schechter MS; Morgan WJ; Pasta DJ; Craib ML; Konstan MW
Pediatr Pulmonol; 2017 Jul; 52(7):909-915. PubMed ID: 28436621
[TBL] [Abstract][Full Text] [Related]
22. Clinical characteristics of Pseudomonas and Aspergillus co-infected cystic fibrosis patients: A UK registry study.
Hughes DA; Archangelidi O; Coates M; Armstrong-James D; Elborn SJ; Carr SB; Davies JC
J Cyst Fibros; 2022 Jan; 21(1):129-135. PubMed ID: 33958279
[TBL] [Abstract][Full Text] [Related]
23. Respiratory pathogens mediate the association between lung function and temperature in cystic fibrosis.
Collaco JM; Raraigh KS; Appel LJ; Cutting GR
J Cyst Fibros; 2016 Nov; 15(6):794-801. PubMed ID: 27296562
[TBL] [Abstract][Full Text] [Related]
24. Clinical outcomes in infants with cystic fibrosis transmembrane conductance regulator (CFTR) related metabolic syndrome.
Ren CL; Desai H; Platt M; Dixon M
Pediatr Pulmonol; 2011 Nov; 46(11):1079-84. PubMed ID: 21538969
[TBL] [Abstract][Full Text] [Related]
25. Age of Pseudomonas aeruginosa acquisition and subsequent severity of cystic fibrosis lung disease.
Pittman JE; Calloway EH; Kiser M; Yeatts J; Davis SD; Drumm ML; Schechter MS; Leigh MW; Emond M; Van Rie A; Knowles MR
Pediatr Pulmonol; 2011 May; 46(5):497-504. PubMed ID: 21194167
[TBL] [Abstract][Full Text] [Related]
26. Association between genetically determined pancreatic status and lung disease in adult cystic fibrosis patients.
Loubières Y; Grenet D; Simon-Bouy B; Medioni J; Landais P; Férec C; Stern M
Chest; 2002 Jan; 121(1):73-80. PubMed ID: 11796434
[TBL] [Abstract][Full Text] [Related]
27. Longitudinal development of mucoid Pseudomonas aeruginosa infection and lung disease progression in children with cystic fibrosis.
Li Z; Kosorok MR; Farrell PM; Laxova A; West SE; Green CG; Collins J; Rock MJ; Splaingard ML
JAMA; 2005 Feb; 293(5):581-8. PubMed ID: 15687313
[TBL] [Abstract][Full Text] [Related]
28. BPI-ANCA Provides Additional Clinical Information to Anti-Pseudomonas Serology: Results from a Cohort of 117 Swedish Cystic Fibrosis Patients.
Lindberg U; Carlsson M; Hellmark T; Segelmark M
J Immunol Res; 2015; 2015():947934. PubMed ID: 26273683
[TBL] [Abstract][Full Text] [Related]
29. Pathophysiology and management of pulmonary infections in cystic fibrosis.
Gibson RL; Burns JL; Ramsey BW
Am J Respir Crit Care Med; 2003 Oct; 168(8):918-51. PubMed ID: 14555458
[TBL] [Abstract][Full Text] [Related]
30. Risk factors for respiratory Aspergillus fumigatus in German Cystic Fibrosis patients and impact on lung function.
Düesberg U; Wosniok J; Naehrlich L; Eschenhagen P; Schwarz C
Sci Rep; 2020 Nov; 10(1):18999. PubMed ID: 33149181
[TBL] [Abstract][Full Text] [Related]
31. Unraveling the complex genetic model for cystic fibrosis: pleiotropic effects of modifier genes on early cystic fibrosis-related morbidities.
Li W; Soave D; Miller MR; Keenan K; Lin F; Gong J; Chiang T; Stephenson AL; Durie P; Rommens J; Sun L; Strug LJ
Hum Genet; 2014 Feb; 133(2):151-61. PubMed ID: 24057835
[TBL] [Abstract][Full Text] [Related]
32. Genetic and clinical features of patients with cystic fibrosis diagnosed after the age of 16 years.
Gan KH; Geus WP; Bakker W; Lamers CB; Heijerman HG
Thorax; 1995 Dec; 50(12):1301-4. PubMed ID: 8553305
[TBL] [Abstract][Full Text] [Related]
33. [Italian Cystic Fibrosis Register - Report 2010].
Amato A; Ferrigno L; Salvatore M; Toccaceli V;
Epidemiol Prev; 2016; 40(2 Suppl 2):1-47. PubMed ID: 27291389
[TBL] [Abstract][Full Text] [Related]
34. [Chinese experts consensus statement: diagnosis and treatment of cystic fibrosis (2023)].
; ;
Zhonghua Jie He He Hu Xi Za Zhi; 2023 Apr; 46(4):352-372. PubMed ID: 36990700
[TBL] [Abstract][Full Text] [Related]
35. Clinical outcome after early Pseudomonas aeruginosa infection in cystic fibrosis.
Nixon GM; Armstrong DS; Carzino R; Carlin JB; Olinsky A; Robertson CF; Grimwood K
J Pediatr; 2001 May; 138(5):699-704. PubMed ID: 11343046
[TBL] [Abstract][Full Text] [Related]
36. Mucus removal is impaired in children with cystic fibrosis who have been infected by Pseudomonas aeruginosa.
Laube BL; Sharpless G; Benson J; Carson KA; Mogayzel PJ
J Pediatr; 2014 Apr; 164(4):839-45. PubMed ID: 24373575
[TBL] [Abstract][Full Text] [Related]
37. [Italian Cystic Fibrosis Registry (ICFR). Report 2017-2018].
Campagna G; Amato A; Majo F; Ferrari G; Quattrucci S; Padoan R; Floridia G; Salvatore D; Carnovale V; Puppo Fornaro G; Taruscio D; Salvatore M;
Epidemiol Prev; 2021; 45(3 Suppl 1):1-37. PubMed ID: 34132083
[TBL] [Abstract][Full Text] [Related]
38. Genetic determinants of airways' colonisation with Pseudomonas aeruginosa in cystic fibrosis.
Kubesch P; Dörk T; Wulbrand U; Kälin N; Neumann T; Wulf B; Geerlings H; Weissbrodt H; von der Hardt H; Tümmler B
Lancet; 1993 Jan; 341(8839):189-93. PubMed ID: 7678316
[TBL] [Abstract][Full Text] [Related]
39. Increased rate of lung function decline in Australian adolescents with cystic fibrosis.
Welsh L; Robertson CF; Ranganathan SC
Pediatr Pulmonol; 2014 Sep; 49(9):873-7. PubMed ID: 24178906
[TBL] [Abstract][Full Text] [Related]
40. CFTR genotype and clinical outcomes of adult patients carried as cystic fibrosis disease.
Bonadia LC; de Lima Marson FA; Ribeiro JD; Paschoal IA; Pereira MC; Ribeiro AF; Bertuzzo CS
Gene; 2014 May; 540(2):183-90. PubMed ID: 24583165
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
